Cytokine imbalance in acute coronary syndrome

Current Opinion in Pharmacology

Volumn 4, Issue 2, 2004, Pages 166-170

  Alam, Samir E ^a   Nasser, Samer S ^a   Fernainy, Khaled E ^a   Habib, Aida A ^a   Badr, Kamal F ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CYTOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RAS PROTEIN; RHO FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CORONARY BLOOD VESSEL; DIAGNOSTIC PROCEDURE; EVIDENCE BASED MEDICINE; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOSIS;

ACUTE DISEASE; ANGINA, UNSTABLE; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; CYTOKINES; HUMANS; MYOCARDIAL INFARCTION; NF-KAPPA B; SIGNAL TRANSDUCTION; SYNDROME;

EID: 1842453952     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2003.10.011     Document Type: Review

References (51)

1. Ross R. Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115-126
2. Libby P. Inflammation in atherosclerosis Nature 420 2002 868-874
3. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes Circulation 104 2001 365-372
4. Keaney Jr. J.F. Vita J.A. The value of inflammation for predicting unstable angina N Engl J Med 347 2002 55-57
5. Schoenhagen P. Tuzcu E.M. Ellis S.G. Plaque vulnerability, plaque rupture, and acute coronary syndromes: (multi)-focal manifestation of a systemic disease process Circulation 106 2002 760-762
6. Rioufol G. Finet G. Ginon I. Andre-Fouet X. Rossi R. Vialle E. Desjoyaux E. Convert G. Huret J.F. Tabib A. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study Circulation 106 2002 804-808
7. Casscells W. Naghavi M. Willerson J.T. Vulnerable atherosclerotic plaque: a multifocal disease Circulation 107 2003 2072-2075
8. Buffon A. Biasucci L.M. Liuzzo G. D'Onofrio G. Crea F. Maseri A. Widespread coronary inflammation in unstable angina N Engl J Med 347 2002 5-12
9. Asakura M. Ueda Y. Yamaguchi O. Adachi T. Hirayama A. Hori M. Kodama K. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study J Am Coll Cardiol 37 2001 1284-1288
10. Andre P. Nannizzi-Alaimo L. Prasad S.K. Phillips D.R. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease Circulation 106 2002 896-899
11. Andre P. Prasad K.S. Denis C.V. He M. Papalia J.M. Hynes R.O. Phillips D.R. Wagner D.D. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism Nat Med 8 2002 247-252
12. Aukrust P. Waehre T. Damas J.K. Gullestad L. Solum N.O. Inflammatory role of platelets in acute coronary syndromes Heart 86 2001 605-606
13. Schonbeck U. Libby P. CD40 signaling and plaque instability Circ Res 89 2001 1092-1103
14. Burke A.P. Kolodgie F.D. Farb A. Weber D. Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis Circulation 105 2002 297-303
15. Libby P. Ridker P.M. Maseri A. Inflammation and atherosclerosis Circulation 105 2002 1135-1143
16. Mallat Z. Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease Circ Res 88 2001 998-1003
17. Aukrust P. Berge R.K. Ueland T. Aaser E. Damas J.K. Wikeby L.Brunsvig A.Muller F. Forfang K. Froland S.S. et al. Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes J Am Coll Cardiol 37 2001 485-491
18. Hajjar D.P. Haberland M.E. Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs J Biol Chem 272 1997 22975-22978
19. Price D.T. Loscalzo J.Cellular adhesion molecules and atherogenesis Am J Med 107 1999 85-97
20. Cybulsky M.I. Iiyama K. Li H. Zhu S. Chen M. Iiyama M. Davis V. Gutierrez-Ramos J.C. Connelly P.W. Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis J Clin Invest 107 2001 1255-1262
21. Plenge J.K. Hernandez T.L. Weil K.M. Poirier P. Grunwald G.K. Marcovina S.M. Eckel R.H. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction Circulation 106 2002 1447-1452
22. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7-22.
23. Crisby M. Nordin-Fredriksson G. Shah P.K. Yano J. Zhu J. Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926-933
24. Brasier A.R. Recinos III. A. Eledrisi M.S. Vascular inflammation and the renin-angiotensin system Arterioscler Thromb Vasc Biol 22 2002 1257-1266
25. Fox K.M. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782-788
26. Dahlof B. Devereux R.B. Kjeldsen S.E. Julius S. Beevers G. Faire U. Fyhrquist F. Ibsen H. Kristiansson K. Lederballe-Pedersen O. et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 2002 995-1003
27. Marx N. PPARgamma and vascular inflammation: adding another piece to the puzzle Circ Res 91 2002 373-374
28. Chinetti G. Lestavel S. Bocher V. Remaley A.T. Neve B. Torra I.P. Teissier E. Minnich A. Jaye M. Duverger N. et al. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway Nat Med 7 2001 53-58
29. O'Shea J.J. Ma A. Lipsky P. Cytokines and autoimmunity Nat Rev Immunol 2 2002 37-45
30. Yamashita H. Shimada K. Seki E. Mokuno H. Daida H. Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris Am J Cardiol 91 2003 133-136
31. Zhou R.H. Shi Q. Gao H.Q. Shen B.J. Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population J Atheroscler Thromb 8 2001 30-32
32. Kiechl S. Wiedermann C.J. Willeit J. Toll-like receptor 4 and atherogenesis Ann Med 35 2003 164-171
33. Wilson S.H. Best P.J. Edwards W.D. Holmes Jr. D.R. Carlson P.J. Celermajer D.S. Lerman A. Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris Atherosclerosis 160 2002 147-153
34. Peng H.B. Libby P. Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B J Biol Chem 270 1995 14214-14219
35. Weyand C.M. Goronzy J.J. Liuzzo G. Kopecky S.L. Holmes Jr D.R. Frye R.L. T-cell immunity in acute coronary syndromes Mayo Clin Proc 76 2001 1011-1020
36. Yeh E.T. Anderson H.V. Pasceri V. Willerson J.T. C-reactive protein: linking inflammation to cardiovascular complications Circulation 104 2001 974-975
37. Blake G.J. Ridker P.M. High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis Eur Heart J 22 2001 349-352
38. Blake G.J. Ridker P.M. C-reactive protein and prognosis after percutaneous coronary intervention Eur Heart J 23 2002 923-925
39. Ridker P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Circulation 103 2001 1813-1818
40. Haffner S. Taegtmeyer H. Epidemic obesity and the metabolic syndrome Circulation 108 2003 1541-1545
41. Festa A. D'Agostino Jr. R. Howard G. Mykkanen L. Tracy R.P. Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 2000 42-47
42. Moukarbel G.V. Arnaout M.S. Alam S.E. C-reactive protein is a marker for a complex culprit lesion anatomy in unstable angina Clin Cardiol 24 2001 506-510
43. Chan A.W. Bhatt D.L. Chew D.P. Reginelli J. Schneider J.P. Topol E.J. Ellis S.G. Relation of inflammation and benefit of statins after percutaneous coronary interventions Circulation 107 2003 1750-1756
44. Fry T.J. Mackall C.L. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 22 2001 564-571
45. Damas J.K. Waehre T. Yndestad A. Otterdal K. Hognestad A. Solum N.O. Gullestad L. Froland S.S. Aukrust P. Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets Circulation 107 2003 2670-2676
46. Gerdes N. Sukhova G.K. Libby P. Reynolds R.S. Young J.L. Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis J Exp Med 195 2002 245-257
47. Mallat Z. Corbaz A. Scoazec A. Besnard S. Leseche G. Chvatchko Y. Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability Circulation 104 2001 1598-1603
48. Blankenberg S. Tiret L. Bickel C. Peetz D. Cambien F. Meyer J. Rupprecht H.J. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina Circulation 106 2002 24-30
49. Tedgui A. Mallat Z. Anti-inflammatory mechanisms in the vascular wall Circ Res 88 2001 877-887
50. Smith D.A. Irving S.D. Sheldon J. Cole D. Kaski J.C. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina Circulation 104 2001 746-749
51. Heeschen C. Dimmeler S. Hamm C.W. Fichtlscherer S. Boersma E. Simoons M.L. Zeiher A.M. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes Circulation 107 2003 2109-2114